LumiraDX And BIVDA Speak On Challenges Of Driving Adoption Of Valuable Diagnostics
Executive Summary
Diagnostics such as c-reactive protein tests are more sensitive than ever before, but manufacturers are still struggling to place them in primary care and community settings where they can make huge differences.